Equivalent Pharmacokinetics of Mycophenolate Mofetil in African-American and Caucasian Male and Female Stable Renal Allograft Recipients
Open Access
- 1 December 2003
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 3 (12) , 1581-1586
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Do Sex and Ethnicity Influence Drug Pharmacokinetics in Solid Organ Transplantation?Graft, 2002
- Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are ComparableThe Journal of Clinical Pharmacology, 2000
- Mycophenolic Acid Area under the Curve Values in African American and Caucasian Renal Transplant Patients Are ComparableThe Journal of Clinical Pharmacology, 2000
- A RANDOMIZED ACTIVE-CONTROLLED TRIAL OF MYCOPHENOLATE MOFETIL IN HEART TRANSPLANT RECIPIENTS1Transplantation, 1998
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- IMMUNOSUPPRESSIVE THERAPY IN HIGH-RISK TRANSPLANT PATIENTSTransplantation, 1997
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejectionThe Lancet, 1995
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987